Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy.

B.1.617.2 COVID-19 E484K Italy SARS-CoV-2 coronavirus disease delta variant mutation of concern respiratory infections severe acute respiratory syndrome coronavirus 2 variant of concern viruses zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 10 9 2021
medline: 25 11 2021
entrez: 9 9 2021
Statut: ppublish

Résumé

The Delta variant of concern of severe acute respiratory syndrome coronavirus 2 is dominant worldwide. We report a case cluster caused by Delta sublineage B.1.617.2 harboring the mutation E484K in Italy during July 11-July 29, 2021. This mutation appears to affect immune response and vaccine efficacy; monitoring its appearance is urgent.

Identifiants

pubmed: 34499599
doi: 10.3201/eid2712.211792
pmc: PMC8632179
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3180-3182

Références

Cell Rep Med. 2021 Apr 20;2(4):100255
pubmed: 33842902
Nat Commun. 2021 Jul 7;12(1):4196
pubmed: 34234131
J Med Virol. 2021 Dec;93(12):6460-6461
pubmed: 34314049

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH